C-Met-IN-12
C-Met-IN-12 (compound 4r) is an orally active, potent and selective type II c-Met kinase inhibitor, with an IC50 of 10.6 nM. c-Met-IN-12 displays high inhibitory effects (inhibition rate > 80% in 1 μM) against AXL, Mer and TYRO3 kinases. c-Met-IN-12 can be used a scaffold for further kinase selectivity enhancement. c-Met-IN-12 shows antitumor efficacy[1].
Product Specifications
CAS Number
2426675-70-7
UNSPSC
12352005
Target
C-Met/HGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/c-met-in-12.html
Solubility
10 mM in DMSO
Smiles
CN(C1=CC=NC(NC2=CC(F)=C(C=C2)OC3=C4C=CC(OCC(C)(O)C)=CC4=NC=C3)=C1C5=O)C=C5C6=CC=CC=C6
Molecular Formula
C34H29FN4O4
Molecular Weight
576.62
References & Citations
[1]Xu H, et al. Discovery of N-substituted-3-phenyl-1,6-naphthyridinone derivatives bearing quinoline moiety as selective type II c-Met kinase inhibitors against VEGFR-2. Bioorg Med Chem. 2020 Jun 15;28 (12) :115555.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1292832-01 0.02 mg (E-Coli)
Recombinant Buchnera aphidicola subsp. Schizaphis graminum Fructose-bisphosphate aldolase class 2 (fbaA)
Sign In for Pricing
View Details MBS1292832-02 0.02 mg (Yeast)
Recombinant Buchnera aphidicola subsp. Schizaphis graminum Fructose-bisphosphate aldolase class 2 (fbaA)
Sign In for Pricing
View Details MBS1292832-03 0.1 mg (E-Coli)
Recombinant Buchnera aphidicola subsp. Schizaphis graminum Fructose-bisphosphate aldolase class 2 (fbaA)
Sign In for Pricing
View Details MBS1292832-04 0.1 mg (Yeast)
Recombinant Buchnera aphidicola subsp. Schizaphis graminum Fructose-bisphosphate aldolase class 2 (fbaA)
Sign In for Pricing
View Details